Privia Health Group (NASDAQ:PRVA) announces earnings results. Privia Health Group (NASDAQ:PRVA - Get Free Report) announced its earnings results on Thursday. The company reported $0.21 earnings per share for the quarter, beating analysts' consensus estimates of $0.09 by $0.12, FiscalAI reports. Privia Health Group had a net margin of 1.19% and a return on equity of 3.52%. The business had revenue of $656.96 million during the quarter, compared to analyst estimates of $610.72 million. During the same period in the previous year, the business earned $0.29 EPS. The company's quarterly revenue was up 13.2% compared to the same quarter last year. Here are the key takeaways from Privia Health Group's conference call: * Privia raised its 2026 outlook above the high end of initial guidance across key financial metrics. At the guidance midpoints, adjusted EBITDA is expected to grow 23.9%, practice collections 13.1%, and care margin 16.3% year over year. * Strong execution drove 12.2% growth in implemented providers and 19.2% growth in attributed lives year over year through the first nine months; adjusted EBITDA rose 21.9% to $114.7 million. Management cited operating leverage, with EBITDA reaching 28.8% of care margin. * Privia agreed to acquire American Choice Healthcare's MSSP ACO for about $36 million in cash. The ACO is expected to bring more than 36,000 attributed lives across 10 existing and three new states beginning in 2027, with minimal impact on 2026 results and a positive contribution to 2027 lives and adjusted EBITDA. * The company expects free-cash-flow conversion of roughly 70%-75% of adjusted EBITDA, citing taxes and the timing of MSSP-related payments; it had previously guided to 70%-80%. Privia ended Q3 with $446.3 million in cash and no debt, and expects at least $520 million at year-end. Privia Health Group stock up 2.0%. Shares of PRVA traded up $0.48 during mid-day trading on Friday, hitting $24.42. 2,807,727 shares of the company traded hands, compared to its average volume of 1,143,537. The company has a market capitalization of $3.12 billion, a PE ratio of 93.93 and a beta of 0.76. Privia Health Group has a 1-year low of $18.92 and a 1-year high of $28.82. The business has a 50 day moving average of $21.04 and a 200 day moving average of $22.64. Analyst upgrades and downgrades. Several research firms have recently commented on PRVA. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Privia Health Group in a research note on Tuesday, September 29th. Canaccord Genuity Group upped their target price on shares of Privia Health Group from $32.00 to $33.00 and gave the company a "buy" rating in a research report on Friday. Citigroup reaffirmed a "buy" rating on shares of Privia Health Group in a research note on Thursday, July 23rd. Zacks Research upgraded Privia Health Group from a "strong sell" rating to a "hold" rating in a research report on Wednesday, August 5th. Finally, Piper Sandler lifted their target price on Privia Health Group from $36.00 to $38.00 and gave the company an "overweight" rating in a research report on Friday. Nine analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $31.25. Key headlines impacting Privia Health Group. Here are the key news stories impacting Privia Health Group this week: * Privia reported Q3 earnings of $0.21 per share, above the $0.09 consensus estimate, and revenue of $656.96 million versus expectations of $610.72 million. Revenue rose 13.2% year over year. * The company raised full-year 2026 guidance across all key financial metrics. Year-to-date adjusted EBITDA was $114.7 million, up 21.9% from the same period in 2025, supporting the improved outlook. * Canaccord Genuity raised its price target from $32 to $33 and maintained a Buy rating. Piper Sandler raised its target from $36 to $38 and kept an Overweight rating, signaling increased analyst confidence. * A valuation analysis argued that PRVA could be undervalued following its earnings beat, adding to the positive post-results narrative. * Despite beating estimates, reported quarterly EPS of $0.21 was below the $0.29 reported a year earlier, a potential caveat for investors weighing the strong revenue growth and raised guidance. Privia Health Group company profile. Privia Health Group, Inc is a physician-enablement company that partners with independent medical practices to support the delivery of coordinated, value-based care. The company provides an integrated platform designed to help physicians manage clinical, administrative and financial functions while maintaining ownership and control of their practices. Its services include practice management, electronic health record and technology support, revenue-cycle management, payer contracting, population-health analytics, care-management programs and administrative assistance. Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.

Privia Health Group Q3 earnings call highlights. Privia Health Group (NASDAQ:PRVA) raised its 2026 financial outlook after reporting growth in providers, patient attribution and adjusted earnings through the first nine months of the year. The company also announced a $36 million acquisition that will expand its Medicare value-based care footprint in 2027. CEO Parth Mehrotra said the revised outlook puts all key financial metrics above the high end of the company's initial guidance. Privia expects to reach 6,000 implemented clinicians by year-end, at the high end of its original provider guidance. At the midpoint of the updated outlook, Privia expects 2026 practice collections to grow 13.1%, care margin to rise 16.3% and adjusted earnings before interest, taxes, depreciation and amortization to increase 23.9% from 2025. Value-based attributed lives are expected to grow 9.2% at the guidance midpoint. Provider growth supports earnings. Privia had 5,893 implemented providers at Sept. 30, up 12.2% from a year earlier and 249 from the second quarter, CFO David Mountcastle said. The company's network served more than 6.3 million patients across 1,400 care centers. For the first nine months of 2026, practice collections rose 12% to $2.91 billion, while adjusted EBITDA increased 21.9% to $114.7 million. Adjusted EBITDA represented 28.8% of care margin. Mehrotra said Privia was on track to add more than 600 providers organically this year, compared with annual additions of roughly 200 to 400 providers five or six years ago. He cautioned that growth would not follow a straight line but said industry disruption could create opportunities to recruit practices. The company served more than 1.67 million attributed lives in value-based arrangements across over 130 commercial, Medicare Advantage and Medicaid programs. Commercial attributed lives rose 11.8% to 966,000, while lives attributed to Centers for Medicare and Medicaid Services programs increased 59%, Mehrotra said. Acquisition adds Medicare lives. Privia agreed to acquire American Choice Healthcare, a Medicare Shared Savings Program accountable care organization owned by Cano Health, for approximately $36 million in cash. The organization is expected to care for more than 36,000 attributed lives beginning in January 2027. The acquisition will expand Privia Care Partners' value-based care presence in 10 existing states and three new states. Privia expects minimal impact on its key 2026 metrics and a positive contribution to attributed lives and adjusted EBITDA in 2027. Mehrotra said approximately 600 providers underlie the 36,000 lives and that many have longstanding relationships with the acquired organization. He said Privia plans to build density around those providers and apply lessons from its prior acquisition of an accountable care organization business from Evolent. Separately, Privia will exit its Montana partnership with Surgery Partners effective January 2027. The partnership supports 69 providers and generates approximately $23 million in annual practice collections; Privia expects no material impact on 2027 adjusted EBITDA. Mehrotra cited several factors in the decision, including the partnership's scale and changing strategic priorities. He said the exit did not alter Privia's interest in ambulatory surgery centers or related services. Cash and capital allocation. Privia ended the third quarter with $446.3 million in cash and no debt. Mountcastle said the company expects at least $520 million in cash at year-end, including the American Choice transaction and assuming the 2025 Medicare Shared Savings Program settlement and related provider payments occur before year-end. The company expects approximately 70% of full-year adjusted EBITDA to convert to free cash flow. Mehrotra and Mountcastle said Privia is targeting a 70% to 75% conversion rate on an ongoing basis as a cash taxpayer, though timing can cause fluctuations. Mehrotra said acquisitions remain the preferred use of capital to compound the business, but the board also evaluates returning capital to shareholders. He said no formal return-of-capital plan had been announced. The company's reported results are preliminary until it files its third-quarter Form 10-Q with the Securities and Exchange Commission, said Robert Borchert, senior vice president of investor and corporate communications. About Privia Health Group (NASDAQ:PRVA). Privia Health Group, Inc is a physician-enablement company that partners with independent medical practices to support the delivery of coordinated, value-based care. The company provides an integrated platform designed to help physicians manage clinical, administrative and financial functions while maintaining ownership and control of their practices. Its services include practice management, electronic health record and technology support, revenue-cycle management, payer contracting, population-health analytics, care-management programs and administrative assistance.